2-42770143-C-CA

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_012205.3(HAAO):​c.483dupT​(p.Asp162fs) variant causes a frameshift, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,603,908 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

HAAO
NM_012205.3 frameshift, splice_region

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 1.06

Publications

1 publications found
Variant links:
Genes affected
HAAO (HGNC:4796): (3-hydroxyanthranilate 3,4-dioxygenase) 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
HAAO Gene-Disease associations (from GenCC):
  • vertebral, cardiac, renal, and limb defects syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • congenital vertebral-cardiac-renal anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-42770143-C-CA is Pathogenic according to our data. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-42770143-C-CA is described in CliVar as Pathogenic. Clinvar id is 403727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HAAONM_012205.3 linkc.483dupT p.Asp162fs frameshift_variant, splice_region_variant Exon 6 of 10 ENST00000294973.11 NP_036337.2 P46952-1
HAAOXM_011532729.4 linkc.393dupT p.Asp132fs frameshift_variant, splice_region_variant Exon 5 of 9 XP_011531031.1
HAAOXM_011532730.4 linkc.381dupT p.Asp128fs frameshift_variant, splice_region_variant Exon 7 of 11 XP_011531032.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HAAOENST00000294973.11 linkc.483dupT p.Asp162fs frameshift_variant, splice_region_variant Exon 6 of 10 1 NM_012205.3 ENSP00000294973.6 P46952-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152180
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000172
AC:
4
AN:
232362
AF XY:
0.0000159
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000388
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000110
AC:
16
AN:
1451728
Hom.:
0
Cov.:
32
AF XY:
0.00000693
AC XY:
5
AN XY:
721396
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33226
American (AMR)
AF:
0.00
AC:
0
AN:
43874
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25892
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39226
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52808
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.0000145
AC:
16
AN:
1106314
Other (OTH)
AF:
0.00
AC:
0
AN:
59964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152180
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Vertebral, cardiac, renal, and limb defects syndrome 1 Pathogenic:2
Sep 21, 2017
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Apr 16, 2018
SIB Swiss Institute of Bioinformatics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as a Pathogenic, for Vertebral, cardiac, renal, and limb defects syndrome 1, Autosomal Recessive inheritance. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PVS1-Strong => PVS1 downgraded in strength to Strong. PS3 => Well-established functional studies show a deleterious effect (PMID:28792876). -

Congenital NAD deficiency disorder Pathogenic:1
Dec 23, 2016
Embryology Laboratory, Victor Chang Cardiac Research Institute
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

This variant was discovered in a consanguineous family of Middle East origin. The patient presented multiple congenital malformations affecting vertebrae, heart and kidney among others. This variant is a protein truncating variant and extremely rare (ExAC MAF 0.00003005). The patient is homozygous, while his unaffected parents and four unaffected siblings are heterozygous for this variant. The patient showed increased plasma concentration of 3HAA and reduced plasma concentration of NAD, consistent with loss of function of the HAAO enzyme activity. Enzyme assay confirmed that the protein product of this gene variant has lost enzyme activity. Mouse embryos homozygous null for Haao presented similar phenotype as observed in the patient, and also showed reduced concentration of NAD in the embryonic tissue. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs527656756; hg19: chr2-42997283; API